Vabicaserin hydrochloride

Base Information

• Chemical Name: Vabicaserin hydrochloride
• CAS No.: 620948-34-7
• Deprecated CAS: 620948-34-7
• Molecular Formula: C₁₅H₂₀N₂*ClH
• Molecular Weight: 264.798
• European Community (EC) Number: 618-208-0
• UNII: 2759C7222C
• ChEMBL ID: CHEMBL2104991
• DSSTox Substance ID: DTXSID70977679
• NCI Thesaurus Code: C142993
• Wikidata: Q27254166
• Mol file: 620948-34-7.mol

Synonyms:Vabicaserin hydrochloride;887258-94-8;Vabicaserin HCl;SCA-136;620948-34-7;SCA 136;Vabicaserin hydrochloride [USAN];Vabicaserin hydrochloride (SCA 136);2759C7222C;887258-94-8 (HCl);(12R,16S)-7,10-diazatetracyclo[8.6.1.05,17.012,16]heptadeca-1,3,5(17)-triene;hydrochloride;Vabicaserin hydrochloride (USAN);(9ar,12as)-4,5,6,7,9,9a,10,11,12,12a-decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline hydrochloride;UNII-2759C7222C;SCHEMBL5477721;CHEMBL2104991;DTXSID70977679;SCA 136SCA 136;AKOS040740510;MS-23744;VABICASERIN HYDROCHLORIDE [WHO-DD];HY-111200;CS-0034625;PF-5208769;PF-05208769;D06660;Q27254166;(-)-(9AR*,12AS*)-4,5,6,7,9,9A,10,11,12,12A-DECAHYDROCYCLOPENTA(4,5)PYRIDO(3,2,1-JK)(1,4)BENZODIAZEPINE MONOHYDROCHLORIDE;(12R,16S)-7,10-diazatetracyclo[8.6.1.0?,??.0??,??]heptadeca-1,3,5(17)-triene hydrochloride;4,5,6,7,9,9a,10,11,12,12a-Decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline--hydrogen chloride (1/1);CYCLOPENTA(4,5)PYRIDO(3,2,1-JK)(1,4)BENZODIAZEPINE, 4,5,6,7,9,9A,10,11,12,12A-DECAHYDRO-, HYDROCHLORIDE (1:1), (9AR,12AS)-;CYCLOPENTA(4,5)PYRIDO(3,2,1-JK)(1,4)BENZODIAZEPINE, 4,5,6,7,9,9A,10,11,12,12A-DECAHYDRO-, MONOHYDROCHLORIDE, (9AR,12AS)-REL-(-)-

Chemical Property of Vabicaserin hydrochloride

Chemical Property:

• Hydrogen Bond Donor Count: 2
• Hydrogen Bond Acceptor Count: 2
• Rotatable Bond Count: 0
• Exact Mass: 264.1393264
• Heavy Atom Count: 18
• Complexity: 291

Purity/Quality:

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

Useful:

• Canonical SMILES: C1CC2CN3CCNCC4=C3C(=CC=C4)C2C1.Cl
• Isomeric SMILES: C1C[C@H]2CN3CCNCC4=C3C(=CC=C4)[C@H]2C1.Cl
• Recent ClinicalTrials: Study Evaluating Safety and Tolerability of Vabicaserin in Patients With Sudden Worsening of Schizophrenia
• Uses: Treatment of schizophrenia.